ResMed Inc.
RMD
$219.72
-$0.50-0.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 65.05% | 41.90% | 27.25% | 29.24% | -7.16% |
| Total Depreciation and Amortization | 6.59% | 1.72% | -0.45% | 4.47% | 17.34% |
| Total Amortization of Deferred Charges | -7.62% | -7.61% | -3.26% | -2.82% | 16.27% |
| Total Other Non-Cash Items | -57.59% | -13.62% | 131.32% | -47.56% | 396.56% |
| Change in Net Operating Assets | -163.72% | -519.52% | 190.69% | 384.95% | 71.48% |
| Cash from Operations | 13.12% | 13.71% | 85.36% | 42.28% | 112.10% |
| Capital Expenditure | 11.60% | 40.60% | 27.77% | 26.46% | 14.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 91.07% | -- | -1,192.45% | -- | 99.24% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.52% | 226.80% | 81.70% | -1,345.72% | -48.26% |
| Cash from Investing | 10.82% | 101.44% | 0.03% | -17.96% | 95.99% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 96.15% | 83.78% | -106.90% | -2.33% | -766.67% |
| Issuance of Common Stock | 37.66% | 752.80% | 17.89% | 397.66% | -11.48% |
| Repurchase of Common Stock | -58.67% | -22,297.33% | -14,997.31% | -8,515.41% | -94.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.93% | -10.33% | -9.04% | -9.05% | -9.58% |
| Other Financing Activities | -- | 33.87% | 100.00% | 100.00% | -- |
| Cash from Financing | 38.26% | 0.25% | -108.54% | -20.16% | -125.61% |
| Foreign Exchange rate Adjustments | -442.32% | 323.16% | 105.55% | -2,436.84% | -22.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8,233.30% | 1,100.48% | 15,133.33% | 209.32% | -97.51% |
